French ski accommodation specialist P&V is offering up to 30% off its Latitudes Hotels in the French Alps, leading to savings of over £500 on
Day: 13 March 2009
Oslo Freedom Forum: Three-day summit will bring together world leaders to honor human rights heroes
The Oslo Freedom Forum, taking place May 18-20 in Norway, will gather some of the world’s leading minds to celebrate heroic survivors of political oppression and
‘Socialising your web presence’: Live Insights at Knexus Digital
Knexus Digital, the digital marketing resource, will host live insights on ‘Web Presence Socialisation’ to help marketers optimize their Social Media strategy online. This content
Online Planning of Theme Weddings and Wedding Web Services: Innovative Solutions at Bridalhome.com
Those in the lookout for something innovative for their wedding can have a look of what is new at Bridalhome.com in the theme wedding and
WORLD WIDE ENTERPRISES RECOMMEND DISKEEPER TO HELP STRETCH TECHNOLOGY BUDGETS
Diskeeper Corporation today announced its multi award–winning defragmenter Diskeeper® 2009 is helping companies through the recession by improving their system performance, thus delaying the need
Performance-based marketing and lead generation: Live Insights at Knexus Digital
Knexus Digital, the essential digital marketing resource, will host live insights on ‘lead generation and performance-based marketing’ to help marketers understand where leads come from,
Rent a Brand New Riverside Apartment at Bridges Wharf, London, SW11
Rent brand new luxury apartments from £310pw Bridges Wharf, Battersea, London, SW11 London-based estate agency Young London (www.younglondon.co.uk) is offering for rent brand new 1
FOOLPROOF UNEARTHS THE 5 KEY DIMENSIONS OF ONLINE TRAVEL SHOPPING
Foolproof has unveiled the five key dimensions of online shopping for holidays and short breaks that travel companies need to address if they are to
Actavis launches Gemcitabine on patent expiry in EU markets
The international generic pharmaceuticals company, Actavis Group, has launched the oncology product Gemcitabine in EU markets, at patent expiry. This launch represents a significant milestone
